nedaplatin has been researched along with Nausea in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (16.13) | 18.2507 |
2000's | 14 (45.16) | 29.6817 |
2010's | 11 (35.48) | 24.3611 |
2020's | 1 (3.23) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Jiang, Y; Song, B | 1 |
Asoda, S; Iwabuchi, H; Kasazaki, S; Shiiba, Y; Suga, K; Uchiyama, K; Uehara, K; Yamada, M | 1 |
Igaki, H; Kobayashi, R; Nakagawa, K; Okuma, K; Omori, M; Yamashita, H | 1 |
Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Mihara, H; Minemura, M; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A; Ueda, Y; Yoshita, H | 1 |
Shi, L; Tang, Y; Teng, XZ; Wang, W | 1 |
Qiu, ZQ; Zhao, K | 1 |
Cao, H; Feng, J; Liu, S; Liu, Y; Ma, R; Wu, J; Yu, S | 1 |
Iwabuchi, H; Komatsu, S; Nakayama, S; Onizawa, K; Souma, T; Uchiyama, K; Yamada, M; Yasui, T | 1 |
Aiba, K; Baba, H; Baba, Y; Kitagawa, Y; Miyazaki, T; Nakajima, Y; Shibata, T; Shimada, H; Shimokawa, M; Tsuji, Y; Yamamoto, S; Yoshikawa, T | 1 |
Chen, XB; Fan, QX; Geng, L; Han, JW; Jiao, ZM; Lu, P; Lu, SP; Lu, TY; Luo, SX; Ma, ZY; Song, M; Wang, GJ; Wang, JS; Wang, R; Wang, RL; Wu, XA; Zhang, MZ; Zhao, YF | 1 |
Chen, ZW; Gu, LP; Shen, SP | 1 |
Cao, KJ; Huang, PY; Luo, DH; Ma, WJ; Xia, WX; Zhang, AL | 1 |
Fujiwara, H; Harada, T; Itamochi, H; Kigawa, J; Machida, S; Oishi, T; Sato, S; Shimada, M; Suzuki, M; Takei, Y | 1 |
Dai, AD; Guan, ZZ; Hu, XH; Huang, H; Jiang, WQ; Li, XG; Liu, YL; Ma, ZY; Pan, LX; Wang, JH; Xie, WM; Xu, RH; Zhang, C; Zhuang, W | 1 |
Azegami, T; Fujimori, S; Kobayashi, H; Koike, T; Kurashina, K; Kurita, H; Ohtsuka, A; Tanaka, K | 1 |
Fujitani, K; Hirao, M; Tsujinaka, T | 2 |
Matsumoto, T; Mikami, T; Momokawa, K; Nakamura, Y; Sakayauchi, T; Sasaki, T; Watanabe, T | 1 |
Ariyosh, Y; Fukuoka, M; Hasegawa, K; Hatae, M; Imajo, Y; Kamiura, S; Kodama, S; Kono, I; Kuzuya, K; Nakayama, H; Nishimura, R; Noda, K; Saji, F; Takahashi, T; Watanabe, Y | 1 |
Abe, S; Araki, H; Hareyama, M; Iyama, S; Kato, J; Miyanishi, K; Murase, K; Nagakura, H; Niitsu, Y; Okamoto, T; Sagawa, T; Sato, T; Sato, Y; Takayama, T; Takimoto, R | 1 |
Feng, FY; Gao, YJ; Guan, XQ; Hu, Y; Li, CW; Liu, JW; Nan, KJ; Suo, AL; Wang, XW; Wu, LY; Zhang, MH; Zhang, P; Zhang, WD; Zhang, Y; Zhao, JB | 1 |
Dai, AD; Guan, ZZ; Hu, XH; Huang, H; Jiang, WQ; Li, XG; Liu, YL; Ma, ZY; Pan, LX; Shi, YX; Wang, JH; Xie, WM; Xu, RH; Zhang, C; Zhuang, W | 1 |
Iwabuchi, H; Nakayama, S; Uchiyama, K | 1 |
Ando, T; Maruoka, Y; Ogiuchi, H; Ogiuchi, Y | 1 |
Hatae, M; Hirabayashi, K; Kanazawa, K; Noda, K; Ozaki, M; Terashima, Y; Yakushiji, M | 1 |
Hashimoto, N; Kamiura, S; Kobayashi, K; Ohira, H; Saji, F; Samejima, Y; Sawai, K; Seino, H | 1 |
Ando, T; Fukada, K; Hoshino, M; Kuwazawa, T; Maruoka, Y; Nishihara, N; Ogiuchi, H; Ogiuchi, Y; Okamoto, T | 1 |
Ariyoshi, Y; Fujii, M; Fukuoka, M; Furuse, K; Hasegawa, K; Kurita, Y; Niitani, H; Nishiwaki, Y; Tamura, M; Yoneda, S | 1 |
Isono, K; Kakegawa, T; Kurihara, M; Nabeya, K; Ota, K; Taguchi, T; Wakui, A | 1 |
Hata, T; Ikeda, M; Kuramoto, H; Nishimura, H; Noda, K; Sasaki, H; Takahashi, T; Tanaka, K; Terashima, Y; Yakushiji, M | 1 |
Koyama, H; Kuraishi, Y; Ogawa, M; Taguchi, T; Tominaga, K; Yoshida, M | 1 |
1 review(s) available for nedaplatin and Nausea
Article | Year |
---|---|
Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis.
Topics: Antineoplastic Agents; Asia, Eastern; Asian People; Carcinoma, Non-Small-Cell Lung; Cisplatin; Databases, Factual; Humans; Lung Neoplasms; Nausea; Odds Ratio; Organoplatinum Compounds; Regression Analysis; Survival Rate; Thrombocytopenia | 2015 |
19 trial(s) available for nedaplatin and Nausea
Article | Year |
---|---|
Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Taxoids; Treatment Failure; Vomiting | 2016 |
Efficacy of S-1 plus nedaplatin compared to standard second-line chemotherapy in EGFR-negative lung adenocarcinoma after failure of first-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Drug Combinations; Drug Therapy; ErbB Receptors; Female; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Tegafur; Treatment Failure; Treatment Outcome; Vomiting | 2014 |
Expression of ERCC1, RRM1 and LRP in non-small cell lung cancers and their influence on chemotherapeutic efficacy of gemcitabine concomitant with nedaplatin.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Nausea; Organoplatinum Compounds; Ribonucleoside Diphosphate Reductase; Thrombocytopenia; Treatment Outcome; Tumor Suppressor Proteins; Vault Ribonucleoprotein Particles; Vomiting | 2014 |
[Nedaplatin or cisplatin combined with 5-fluorouracil for treatment of stage III-IVa nasopharyngeal carcinoma: a randomized controlled study].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Nausea; Neoplasm Staging; Organoplatinum Compounds; Remission Induction; Vomiting | 2011 |
Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies.
Topics: Adult; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Camptothecin; Dose-Response Relationship, Drug; Female; Genetic Variation; Genital Neoplasms, Female; Glucuronosyltransferase; Humans; Irinotecan; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds | 2012 |
[Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Organoplatinum Compounds; Treatment Outcome | 2002 |
Phase I study of the combination of nedaplatin, adriamycin and 5-fluorouracil for treatment of advanced esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; Doxorubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Platelet Count; Treatment Outcome | 2004 |
[Phase I study of the combination of nedaplatin (NED), adriamycin (ADM), and 5-fluorouracil (5-FU) (NAF) for treatment of unresectable advanced esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Feasibility Studies; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds | 2005 |
[A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukopenia; Maximum Tolerated Dose; Middle Aged; Nausea; Organoplatinum Compounds; Uterine Cervical Neoplasms; Vomiting, Anticipatory | 2005 |
A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagitis; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Radiotherapy, Adjuvant; Remission Induction; Severity of Illness Index; Survival Rate; Thrombocytopenia; Treatment Outcome | 2006 |
[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Organoplatinum Compounds; Ovarian Neoplasms; Vinblastine; Vinorelbine | 2006 |
[Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Prospective Studies; Remission Induction; Thrombocytopenia | 2006 |
[Phase I/II clinical trial of induction chemotherapy with nedaplatin (CDGP), docetaxel (DOC) and 5-fluorouracil (5-FU) for squamous cell carcinoma of head and neck].
Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Quality of Life; Taxoids | 2007 |
[Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Ifosfamide; Middle Aged; Nausea; Organoplatinum Compounds; Pilot Projects; Uterine Cervical Neoplasms; Vomiting | 1997 |
[Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diarrhea; Drug Administration Schedule; Female; Humans; Hysterectomy; Infusions, Intravenous; Middle Aged; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms; Vomiting, Anticipatory | 2001 |
[Combination chemotherapy with nedaplatin (CDGP) and 5-FU for oral cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Nausea; Organoplatinum Compounds; Vomiting, Anticipatory | 2002 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Organoplatinum Compounds | 1992 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Topics: Antineoplastic Agents; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Esophageal Neoplasms; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Nausea; Organoplatinum Compounds; Stomach Neoplasms; Thrombocytopenia | 1992 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast cancer].
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Organoplatinum Compounds; Vomiting | 1992 |
11 other study(ies) available for nedaplatin and Nausea
Article | Year |
---|---|
Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Topics: Abdominal Pain; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Case-Control Studies; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Exanthema; Female; Humans; Hyperglycemia; Irinotecan; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms; Vomiting | 2022 |
[Determination of the Effect of Aprepitant and Fosaprepitant for Nausea in Patients with Oral Cancer Receiving Combination Chemotherapy with TPF].
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Morpholines; Nausea; Organoplatinum Compounds; Taxoids | 2017 |
Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Longitudinal Studies; Male; Middle Aged; Nausea; Organoplatinum Compounds; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vomiting | 2014 |
[Determination of the Appropriate Timing of Aprepitant Administration for Nausea in Patients with Head and Neck Cancer Receiving Combination Chemotherapy with Docetaxel, Nedaplatin(Divided Doses for 5 Days), and 5-fluorouracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Morpholines; Nausea; Organoplatinum Compounds; Taxoids; Time Factors | 2015 |
Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Esophageal Neoplasms; Female; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nausea; Organoplatinum Compounds; Prospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting | 2017 |
[Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Tegafur; Vomiting | 2008 |
[Comparison of the efficacy of nedaplatin combined with docetaxel and docetaxel alone as a second line treatment for advanced non-small cell lung cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Taxoids; Vomiting | 2010 |
[Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Topics: Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Preoperative Care; Tegafur; Uracil | 2003 |
[Effect of steroid on antiemetic for side effect of anticancer chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Neoplasms; Fluorouracil; Humans; Male; Metoclopramide; Middle Aged; Nausea; Organoplatinum Compounds; Serotonin Antagonists; Stomach Neoplasms; Vomiting, Anticipatory | 2005 |
[Nedaplatin (NDP)-combination therapy (NDP/5-FU,NDP/S-1) for oral cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Nausea; Organoplatinum Compounds; Oxonic Acid; Tegafur; Thrombocytopenia; Vomiting, Anticipatory | 2007 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Organoplatinum Compounds; Uterine Cervical Neoplasms | 1992 |